Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 0.00% is 100% below its 5-year average of 27.72%, near the high end of its 5-year range (-234.79%–100.00%).
100.00% below its 12-month average of 17.66%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 88.32%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
17.66%
GROSS MARGIN AVG 3Y
34.45%
GROSS MARGIN AVG 5Y
27.72%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Werewolf Therapeutics, Inc.
Market Cap
$45.03M
Gross Margin
0.00%
TTM Avg
17.66%
3Y Avg
34.45%
5Y Avg
27.72%
Market Cap
$45.20M
Gross Margin
75.20%
TTM Avg
76.17%
3Y Avg
74.22%
5Y Avg
71.65%
Market Cap
$44.27M
Gross Margin
56.09%
TTM Avg
52.85%
3Y Avg
42.50%
5Y Avg
40.42%
Market Cap
$43.70M
Gross Margin
22.65%
TTM Avg
11.13%
3Y Avg
-12.99%
5Y Avg
-22.58%
Market Cap
$43.11M
Gross Margin
93.13%
TTM Avg
94.29%
3Y Avg
92.05%
5Y Avg
80.64%
Market Cap
$42.93M
Gross Margin
-98.21%
TTM Avg
-96.12%
3Y Avg
-84.75%
5Y Avg
-75.83%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | $45.03M | 0.00% | 17.66% | 34.45% | 27.72% |
| SANUWAVE Health Inc. (SNWV)vs › | $45.20M | 75.20% | 76.17% | 74.22% | 71.65% |
| DarioHealth Corp. (DRIO)vs › | $44.27M | 56.09% | 52.85% | 42.50% | 40.42% |
| CVRx, Inc. (CVRX)vs › | $44.01M | 86.60% | 84.54% | 82.73% | 79.87% |
| Celularity Inc. (CELU)vs › | $46.31M | 79.62% | 74.20% | 42.17% | 48.15% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $43.70M | 22.65% | 11.13% | -12.99% | -22.58% |
| Instil Bio, Inc. (TIL)vs › | $47.41M | 0.00% | 0.00% | 0.00% | 16.67% |
| BioStem Technologies, Inc. (BSEM)vs › | $43.11M | 93.13% | 94.29% | 92.05% | 80.64% |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.93M | -98.21% | -96.12% | -84.75% | -75.83% |
| Lite Strategy, Inc. (LITS)vs › | $47.81M | 0.00% | 0.00% | 50.00% | 65.99% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 88.32% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 60.28% |
| 2024-03-31 | 37.47% |
| 2023-12-31 | 69.35% |
| 2023-09-30 | 92.45% |
| 2023-06-30 | 100.00% |
| 2023-03-31 | 100.00% |
| 2022-12-31 | -79.24% |
| 2022-09-30 | 85.75% |
| 2022-06-30 | -234.79% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
